NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000018104

Registered date:26/06/2015

Withdrawal and Dose Reduction of Pioglitazone in Patients with Type 2 Diabetes: A Chart-Based Analysis

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedType 2 diabetes
Date of first enrollment2014/09/01
Target sample size71
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeThe change of body weight, plasma glucose, HbA1c, HDL, LDL, TG, AST, ALT after the dose reduction and withdrawal of pioglitazone
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum100years-old
GenderMale and Female
Include criteria
Exclude criteriaType 1 diabetes Secondary diabetes

Related Information

Contact

public contact
Name Hisayuki Katsuyama
Address 1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan
Telephone +81-47-272-0034
E-mail katsuyama-hs@umin.org
Affiliation National Center for Global Health and Medicine Kohnodai Hospital Department of Internal Medicine
scientific contact
Name Hisayuki Katsuyama
Address 1-7-1 Kohnodai, Ichikawa, Chiba, 272-0034, Japan
Telephone +81-47-272-0034
E-mail katsuyama-hs@umin.org
Affiliation National Center for Global Health and Medicine Kohnodai Hospital Department of Internal Medicine